Cardiac Rehabilitation During the COVID-19 Era: Guidance on Implementing Virtual Care.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
08 2020
Historique:
received: 21 05 2020
revised: 07 06 2020
accepted: 08 06 2020
pubmed: 20 6 2020
medline: 26 8 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

Cardiac rehabilitation programs across Canada have suspended in-person services as a result of large-scale physical distancing recommendations designed to flatten the COVID-19 pandemic curve. Virtual cardiac rehabilitation (VCR) offers an alternate mechanism of care delivery, capable of providing similar patient outcomes and safety profiles compared with centre-based programs. To minimize care gaps, all centres should consider developing and implementing a VCR program. The process of this rapid implementation, however, can be daunting. Centres should initially focus on the collation, utilization, and repurposing of existing resources, equipment, and technology. Once established, programs should then focus on ensuring that quality indicators are met and care processes are protocolized. This should be followed by the development of sustainable VCR solutions to account for care gaps that existed before COVID-19, and to improve cardiac rehabilitation delivery, moving forward. This article reviews the potential challenges and obstacles of this process and aims to provide pragmatic guidance to aid clinicians and administrators during this challenging time.

Identifiants

pubmed: 32553606
pii: S0828-282X(20)30534-1
doi: 10.1016/j.cjca.2020.06.006
pmc: PMC7293761
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1317-1321

Informations de copyright

Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Références

Can J Cardiol. 2014 Aug;30(8):945-8
pubmed: 25064585
Can J Cardiol. 2016 Oct;32(10 Suppl 2):S358-S364
pubmed: 27692116
Can J Cardiol. 2020 Jun;36(6):792-794
pubmed: 32344000
Circulation. 2007 Jul 17;116(3):329-43
pubmed: 17576872
J Am Coll Cardiol. 2019 Jul 9;74(1):133-153
pubmed: 31097258

Auteurs

Nathaniel Moulson (N)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

David Bewick (D)

New Brunswick Heart Centre, Saint John, New Brunswick, Canada. Electronic address: bewickd@nbnet.nb.ca.

Tracy Selway (T)

New Brunswick Heart Centre, Saint John, New Brunswick, Canada.

Jennifer Harris (J)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Neville Suskin (N)

Western University, London, Ontario, Canada.

Paul Oh (P)

University Health Network, University of Toronto, Toronto, Ontario, Canada.

Thais Coutinho (T)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Gurmeet Singh (G)

Mazankowski Alberta Hearth Institute, Departments of Critical Care Medicine and Surgery, Division of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.

Chi-Ming Chow (CM)

Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Brian Clarke (B)

Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.

Simone Cowan (S)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Christopher B Fordyce (CB)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Anne Fournier (A)

CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.

Kenneth Gin (K)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Anil Gupta (A)

Trillium Health Partners, University of Toronto, Mississauga, Ontario, Canada.

Sean Hardiman (S)

Cardiac Services BC, Provincial Health Services Authority, Vancouver, British Columbia, Canada.

Simon Jackson (S)

QEII Health Sciences Center, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Yoan Lamarche (Y)

Department of Surgery, Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada.

Benny Lau (B)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Jean-François Légaré (JF)

New Brunswick Heart Centre, Saint John, New Brunswick, Canada.

Howard Leong-Poi (H)

Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

Samer Mansour (S)

Department of Medicine, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada.

Ariane Marelli (A)

McGill University Health Center, Department of Medicine, McGill University, Montréal, Québec, Canada.

Ata Ur Rehman Quraishi (AUR)

QEII Health Sciences Center, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Idan Roifman (I)

Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Marc Ruel (M)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

John Sapp (J)

QEII Health Sciences Center, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Gary Small (G)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Ricky Turgeon (R)

Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

David A Wood (DA)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Shelley Zieroth (S)

University of Manitoba, Winnipeg, Manitoba, Canada.

Sean Virani (S)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Andrew D Krahn (AD)

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH